Clinical Trial

A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors

Name: A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors — clinical trial record (NCT07482319)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

An Open-label, Single-arm, Phase I Clinical Study of GK01 Cell Injection in the Treatment of Patients with Advanced Malignant Solid Tumors

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-16.

Trial Details

NCT Number	NCT07482319
Lead Sponsor	Beijing Geekgene Technology Co., LTD Collaborators: Peking University Cancer Hospital & Institute
Conditions	Advanced Solid Tumors
Enrollment	15 participants
Start Date	2026-04
Primary Completion	2026-12 (estimated)
Study Completion	2028-04 (estimated)
Updated on ClinicalTrials.gov	2026-03-23